Key result
Higher VAT links to incident CVD, with accelerated heart ageing explaining ~14% of this risk.
Why the study?
Obesity contributes significantly to CVD, but whether distinct fat depots uniquely influence cardiac ageing and cardiovascular risk beyond anthropometric measures remains unclear.
Do imaging-defined adiposity phenotypes better predict biological heart ageing and incident CVD compared to BMI in individuals without CVD?
Population
34 496 UK Biobank participants without CVD
Comparison
Imaging-defined adiposity phenotypes vs anthropometric measures
Design
Observational cohort study
Authors
Loading...
Captured external expert commentary on this paper, strongest first. Original sources are linked where available.
“Visceral adipose tissue, we all knew, is not good. What was not so clear is that there's a difference between men and women, it seems, in terms of the fat distribution.”
Imaging phenotypes may refine CVD risk assessment beyond BMI; leaves open whether they improve outcomes or warrant routine use.
Cohort (n=34,496)
Do imaging-defined adiposity phenotypes better predict biological heart ageing and incident CVD compared to BMI in individuals without CVD?
Visceral adipose tissue is the strongest driver of cardiovascular ageing and incident CVD among fat depots, outperforming BMI and pericardial fat.
Maldonado-Garcia et al. (2026) conducted a cohort in Without cardiovascular disease (n=34,496). Compartment-specific fat distribution (VAT, ASAT, PAT) vs. Lower-risk adiposity phenotype / BMI categories was evaluated on Biological heart ageing and incident CVD. Visceral adipose tissue (VAT) showed the strongest relationship with incident CVD, explaining 14% of its association with incident CVD through accelerated heart ageing.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: